progress better set
colgat
toothpast pet food good news view far offset
issu gross margin look transitori
cl share trade gm contract bp
guidance/ consensu
arguabl midst turnaround manag quarterli
guidanc item gm subject extern like fx
commod creat nois particularli colgat
portfolio complex appreci
care account sale emerg market
cl valuat stapl look attract histori
oper see good setup toward china
brazil appear turn corner ii diversif
therapeut natur gain traction iii
momentum pet food set continu iv innov
yet visibl focus drive premium
turnaround rare follow straight-lin trajectori
colgat seem close pull one toothpast pet
food sale post best growth year
underscor strategi work reinvest
organ sale sped area concern
either turn corner better brazil china india
growth well-balanc geograph despit slower
 across product categori includ
underutil premium brand tom main elmex
deploy geograph work
skin health alreadi move needl
stop give gm guidanc pleas colgat might limit
constrain turnaround time consum
tast distribut channel drugstor on-line shift
rapidli specif one thing inform strateg decis
gm colgat hallmark creat tremend
valu anoth intend gm expans given quarter
mani extern factor delay expans
concern emphasi howev commend
us investor chang estim
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
exhibit cl ntm pe rel stapl xlp revers mean
rel stapl xlp
cl in-lin progress core initi
cl brazil focus premium punch low hard need
cl dare initi outperform
arriv target per cl share base rel intrins valuat methodolog
discount cash flow model point fair valu per share use wacc
growth termin valu base project ep growth
target impli forward price-to-earnings premium today xlp stapl sector
pt impli regress mean share trade rang re-rat cl share
histor averag predic convict health global oral care market
colgat capac recalibr portfolio busi model restart market share gain
widen leadership believ challeng pressur cl valuat structur
expens deal street fear like manag restructur save
back-end load cl afford higher reinvest power
there limit downsid risk given cl trade one standard deviat trade averag vs stapl
sector model assum improv macro environ brazil key profit center firm colgat
success diversifi portfolio natur therapeut oral care howev greatest risk stem increas
competit busi outsid oral care home care person care categori colgat lack financi
incent reinvest structur part cl person care busi becom less attract colgat person care
busi compos region brand miss structur premium categori
articl articl
time dissemin novemb
analyst yutong zhou javier escalant robert ottenstein primarili respons prepar research report attest
follow view opinion render research report reflect person view subject compani
issuer part research analyst compens directli relat specif recommend view
research report
